Salomon

“Just on launching the second most new smart apps, how does that shake out when it comes to the number of patients it supplies to versus past app launches? And, you know, you've talked about that being a big driver of G360 volumes in the past.”

“I know it's pretty easy or early in the process there, but I don't know if you've had any conversations with your customers on how they think that will ramp and what the ordering patterns will be there and what's kind of contemplated in the guide from a GLP-1 perspective.”

“Is the expectation still to place somewhere in the realm of three to four UHF NMRs this year, kind of in line with the four you've placed in the past couple years?”

“Just to start off, could you guys provide a little more detail on what you expect the revenue contribution will be for the outreach lab services business acquisition you guys had with university hospitals?”